Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Mucus Proteins May Control Asthma
Disease Discoveries

Mucus Proteins May Control Asthma

By Nora DunneJan 13, 2015
Share
Facebook Twitter Email
Too many eosinophils in the airway worsen asthma (A). The study found that unique sugars on mucus protein Muc5b activate sugar-binding protein Siglec-F to prompt eosinophil death (B). Medical illustration by Jacqueline Schaffer.

Eosinophils are a type of white blood cell meant to attack parasites, but when too many of them get activated in tissues they can worsen asthma, allergies, eczema and other chronic diseases. Northwestern Medicine scientists have revealed that sugars on a specific mucus protein can induce eosinophil death and help combat asthma.

“Asthmatics often have too many eosinophils in their airways,” said Bruce Bochner, MD, Samuel M. Feinberg Professor in Medicine, Medicine-Allergy/Immunology. “About 15 years ago, we embarked on research efforts to find new targets for treatment related to these cells.”

Dr. Bochner and others previously discovered a sugar-binding protein on the surface of human eosinophils called Siglec-8. When activated, the protein signals eosinophils to undergo programmed cell death, or apoptosis. In the new study, published in the Journal of Allergy and Clinical Immunology, he and collaborators searched for sugars that occur naturally in the body that can trigger Siglec-8.

Investigating Siglec-F, the version of Siglec-8 expressed in mice, the scientists found in vitro and in vivo that unique sugars on the mucus protein Muc5b activate Siglec-F to prompt eosinophil death.

“We showed that mice missing Muc5b develop worse eosinophilic inflammation in their airways. If you incubate this specific mucin with eosinophils, not only does it bind to Siglec-F, but when it does, it kills the eosinophils,” Dr. Bochner said.

The findings suggest that airway mucins are an important pathway for reducing high levels of unwanted eosinophils. Further research on the specific sugars at play could lead to novel treatments for asthma.

“Maybe we can enhance the body’s own ability to get rid of these wayward eosinophils that shouldn’t be in the airway,” Dr. Bochner said.

Ongoing work is testing the findings in human cells.

The study was conducted in collaboration with the University of Georgia and the University of Colorado. It was supported by National Institutes of Health (NIH) grants AI72265, HL080396, ES023384, HL109517, P41 GM103490 and HL107151 and American Heart Association grant 14GRNT19990040.

Immunology Pulmonology Research
Share. Facebook Twitter Email

Related Posts

Scientists Discover Novel Cellular Mechanisms Behind Transcription Elongation

Aug 10, 2022

‘Inside Out’ Signaling Promotes Tumor Growth

Aug 5, 2022

New Insights in Retinal Neurons

Aug 4, 2022

Comments are closed.

Latest News

Scientists Discover Novel Cellular Mechanisms Behind Transcription Elongation

Aug 10, 2022

First-Year Medical Students Celebrate Founders’ Day 2022

Aug 9, 2022

‘Inside Out’ Signaling Promotes Tumor Growth

Aug 5, 2022

New Insights in Retinal Neurons

Aug 4, 2022

Medical Student Wins Presidential Fellowship

Aug 3, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
220805_SERIO_MANDELL_FEINBERG_White_Coat_1676
220805_SERIO_MANDELL_FEINBERG_White_Coat_1206
220805_SERIO_MANDELL_FEINBERG_White_Coat_1144 (1)
220805_SERIO_MANDELL_FEINBERG_White_Coat_1133
220805_SERIO_MANDELL_FEINBERG_White_Coat_1057
220805_SERIO_MANDELL_FEINBERG_White_Coat_1424
220805_SERIO_MANDELL_FEINBERG_White_Coat_1472
220805_SERIO_MANDELL_FEINBERG_White_Coat_1573
220805_SERIO_MANDELL_FEINBERG_White_Coat_1671
220805_SERIO_MANDELL_FEINBERG_White_Coat_1793
220805_SERIO_MANDELL_FEINBERG_White_Coat_0885
220805_SERIO_MANDELL_FEINBERG_White_Coat_1144

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.